# Efficacy and Safety of MiSight ® Contact Lenses in Reducing the Progression of Childhood Myopia.

> **NCT01917110** · NA · COMPLETED · sponsor: **CooperVision, Inc.** · enrollment: 79 (actual)

## Conditions studied

- Myopia

## Interventions

- **DEVICE:** omafilcon A
- **DEVICE:** Spectacle

## Key facts

- **NCT ID:** NCT01917110
- **Lead sponsor:** CooperVision, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-13
- **Primary completion:** 2016-06-16
- **Final completion:** 2016-06-16
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2020-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01917110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01917110, "Efficacy and Safety of MiSight ® Contact Lenses in Reducing the Progression of Childhood Myopia.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01917110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*